Cytosorbents Corp (CTSO) stock
CTSONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$5.57+1.05 (+23.12%)
Close on Nov 18, 2026Market cap $349.72MP/E –Yield –
Cytosorbents net income
Net income is the profit left for shareholders after every expense, interest and tax.
Cytosorbents's net income for the twelve months ending Jun 30, 2026 was -$18.21M. For fiscal 2025 it was -$8.20M. The highest annual figure on record is -$1.10M in fiscal 2004.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$8.20M | – |
| FY2024 | Dec 31, 2024 | -$20.72M | – |
| FY2023 | Dec 31, 2023 | -$29.25M | – |
| FY2022 | Dec 31, 2022 | -$32.81M | – |
| FY2021 | Dec 31, 2021 | -$24.56M | – |
| FY2020 | Dec 31, 2020 | -$7.84M | – |
| FY2019 | Dec 31, 2019 | -$19.27M | – |
| FY2018 | Dec 31, 2018 | -$17.21M | – |
| FY2017 | Dec 31, 2017 | -$8.46M | – |
| FY2016 | Dec 31, 2016 | -$11.76M | – |
| FY2015 | Dec 31, 2015 | -$9.48M | – |
| FY2014 | Dec 31, 2014 | -$9.32M | – |
| FY2013 | Dec 31, 2013 | -$4.68M | – |
| FY2012 | Dec 31, 2012 | -$3.66M | – |
| FY2011 | Dec 31, 2011 | -$5.48M | – |
| FY2010 | Dec 31, 2010 | -$2.91M | – |
| FY2009 | Dec 31, 2009 | -$2.74M | – |
| FY2008 | Dec 31, 2008 | -$3.02M | – |
| FY2007 | Dec 31, 2007 | -$3.35M | – |
| FY2006 | Dec 31, 2006 | -$76.72M | – |
| FY2005 | Dec 31, 2005 | -$3.67M | – |
| FY2004 | Dec 31, 2004 | -$1.10M | – |
| FY2003 | Dec 31, 2003 | -$6.01M | – |
| FY2002 | Dec 31, 2002 | -$11.87M | – |
| FY2001 | Dec 31, 2001 | -$15.39M | – |
| FY2000 | Dec 31, 2000 | -$3.07M | – |
| FY1999 | Dec 31, 1999 | -$10.75M | – |
| FY1998 | Dec 31, 1998 | -$1.87M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$4.42M | -326.9% |
| Q1 FY2026 | Mar 31, 2026 | -$5.13M | – |
| Q4 FY2025 | Dec 31, 2025 | -$5.50M | – |
| Q3 FY2025 | Sep 30, 2025 | -$3.17M | – |
| Q2 FY2025 | Jun 30, 2025 | $1.95M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.48M | – |
| Q4 FY2024 | Dec 31, 2024 | -$7.57M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.77M | – |
| Q2 FY2024 | Jun 30, 2024 | -$4.29M | – |
| Q1 FY2024 | Mar 31, 2024 | -$6.09M | – |
| Q4 FY2023 | Dec 31, 2023 | -$6.57M | – |
| Q3 FY2023 | Sep 30, 2023 | -$9.19M | – |
| Q2 FY2023 | Jun 30, 2023 | -$6.15M | – |
| Q1 FY2023 | Mar 31, 2023 | -$7.33M | – |
| Q4 FY2022 | Dec 31, 2022 | -$766.13K | – |
| Q3 FY2022 | Sep 30, 2022 | -$12.20M | – |
| Q2 FY2022 | Jun 30, 2022 | -$10.88M | – |
| Q1 FY2022 | Mar 31, 2022 | -$8.97M | – |
| Q4 FY2021 | Dec 31, 2021 | -$9.31M | – |
| Q3 FY2021 | Sep 30, 2021 | -$6.41M | – |
| Q2 FY2021 | Jun 30, 2021 | -$4.68M | – |
| Q1 FY2021 | Mar 31, 2021 | -$4.17M | – |
| Q4 FY2020 | Dec 31, 2020 | -$677.72K | – |
| Q3 FY2020 | Sep 30, 2020 | -$839.73K | – |
| Q2 FY2020 | Jun 30, 2020 | -$2.87M | – |
| Q1 FY2020 | Mar 31, 2020 | -$3.45M | – |
| Q4 FY2019 | Dec 31, 2019 | -$3.95M | – |
| Q3 FY2019 | Sep 30, 2019 | -$6.89M | – |
| Q2 FY2019 | Jun 30, 2019 | -$3.55M | – |
| Q1 FY2019 | Mar 31, 2019 | -$4.88M | – |
| Q4 FY2018 | Dec 31, 2018 | -$5.40M | – |
| Q3 FY2018 | Sep 30, 2018 | -$3.00M | – |
| Q2 FY2018 | Jun 30, 2018 | -$5.82M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.98M | – |
| Q4 FY2017 | Dec 31, 2017 | -$3.15M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.05M | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.73M | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.52M | – |
| Q4 FY2016 | Dec 31, 2016 | -$4.91M | – |
| Q3 FY2016 | Sep 30, 2016 | -$2.19M | – |
See a number that looks wrong?